We are looking for a Quality Assurance Specialist for our production site in Fribourg. At this position, you work within the Release Team and are responsible for the review of batch records prior to the final release as well as the follow-up of related quality topics in agreement with cGMPs.
Your main activities are:
- Batch record review
- Follow-up of non-conformities linked with batches review
- Management of OOx & Deviations
- Establishment and/or review/approval of investigation reports
For this interesting role, we are looking for a dynamic person with the following profile:
- Scientific academic education in pharmacy, chemistry or biology
- First experience with cGMPs (EC GMP Guide; 21CFRpart211, FDA) and related guidelines
- Professional in French, both in oral and written communications
- Experienced in English, both in oral and written communications
You are a well-organized personality with good scientific knowledge. Thanks to your good communication skills, you have the ability to efficiently communicate orally and in writing and interact easily with other departments. You bring a systematic approach to resolve different types of issues and are able to work effectively in cross-functional teams.
We are looking forward to receiving your application.About Us The Vifor Pharma Group
is a global specialty pharmaceuticals company. It aims to become the global leader in iron deficiency, nephrology and cardio-renal therapies. The company is the partner of choice for pharmaceuticals and innovative patient-focused solutions. Vifor Pharma Group strives to help patients around the world with severe and chronic diseases lead better, healthier lives. The company develops, manufactures and markets pharmaceutical products for precision patient care. Vifor Pharma Group holds a leading position in all its core business activities and consists of the following companies: Vifor Pharma; Vifor Fresenius Medical Care Renal Pharma (a joint company with Fresenius Medical Care); and OM Pharma.
Vifor Pharma Group is headquartered in Switzerland, and listed on the Swiss Stock Exchange (SIX Swiss Exchange, VIFN, ISIN: CH0364749348).
For more information, please visit www.viforpharma.com/career